Skip to NavigationSkip to content

MSF

Médecins Sans Frontières (MSF)/ Doctors Without Borders calls on CEPI to revise 'toothless' access policy

Image Credit: Mark Knobil

The humanitarian organisation Médecins Sans Frontières (MSF) has called on The Coalition for Epidemic Preparedness Innovations (CEPI) to revise their access policy, ahead of the coalition’s board meeting in Tokyo on the 7-8 March.

Established in 2017, CEPI was founded as a public-private coalition, with the aim of preventing and containing new epidemics of infectious diseases, through financing and facilitating the development of vaccines.

MSF warns of antibiotic resistance crisis in Gaza

Image Credit: Boris Niehaus

The international non-governmental organisation (NGO) Médecins Sans Frontières (MSF) has warned that antibiotic resistant infections are a “certainty” in Gaza.

The medical NGO has declared that “action must be taken,” to prevent an epidemic of antibiotic resistance in the Israeli occupied Palestinian territory.

The NGO has suggested that the crisis has been compounded in recent months by “the violent response of Israeli forces to Palestinian protestors in Gaza”.

MSF says staff member shot dead in Central African Republic; suspends activity in the area

The medical aid charity Doctors without Borders (MSF) said it is suspending activities in the Central African Republic (CAR) following an attack on its team in which a staff member was shot dead by armed men.

MSF said it will discontinue operations in the area until such time as it receives adequate guarantees for the safety for its staff and the acceptance of its medical and humanitarian activities, the charity said on its website. 

MSF launches global action against GSK and Pfizer over pneumonia vaccine price

MSF poster
The charity MSF is calling for pharma companies to make pneumococcal vaccines cheaper, on World Pneumonia Day

International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the public to pressurise the pharma companies into reducing the price of pneumonia vaccines.

MSF is drumming up support through a petition and social sharing videos asking “for a fair price and transparent negotiations,” via the website AFAIRSHOT.ORG.

MSF campaigns to uphold cheap Indian generics

india image

Charity Médecins Sans Frontières is urging Indian prime minister Narendra Modi to stand tall and not give in to pressure from the US, Japan and Europe to change India’s laws and policies which could restrict the country’s ability to produce affordable medicines. 

Also known as Doctors Without Borders (MSF), the humanitarian aid organisation says changes put forward at negotiations for the Regional Comprehensive Economic Partnership (RCEP) trade ag

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

Published on 27/04/15 at 01:26pm

YES - says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that blaming the pharma patent system for hepatitis C drugs’ prices is a non-starter.

New hepatitis C treatments have been a regular feature in healthcare news of late, not least because they offer that most elusive of gifts: a cure.

MSF starts trials of Ebola candidates

MSF image

Three experimental Ebola therapies will be tested at sites operated by Médecins Sans Frontières (MSF) in West Africa, according to the medical charity which hopes to report data by February.

The trials were announced just after the death toll for Ebola passed the 5,100 mark, with more than 14,000 cases recorded centred particularly around Guinea, Liberia and Sierra Leone.  Two will take place at centres in Guinea, with the location of the third yet to be decided. 

Gilead runs into India patent trouble

Gilead image

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new hepatitis C treatment sofosbuvir.

The US-based not-for-profit group Initiative for Medicines, Access & Knowledge (I-MAK) has filed a ‘patent opposition’ at India’s Patent Office and is supported by Médecins Sans Frontières (MSF).

Both groups are aghast at the treatment’s ‘anticipated exorbitant price’.

Novartis’ Indian patent case delayed

Novartis image

Novartis’ court case against the Indian government has been put on hold until next month.

The case was suppose to be heard in August, but has been put back until 11 September as the Indian court looks to clear a backlog of other cases.

Novartis took the Indian government to court in 2006 to overturn a public health provision that stopped Novartis from being able to patent Glivec, which is licensed for certain types of blood cancer and GIST.

Pharma R&D model no help to developing countries

R&D image
The MSF believes that pharma's R&D model is flawed

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps people in poorer countries.

The world’s health ministers are gathering in Geneva for the World Health Assembly (WHA) this week, and will decide whether or not to start the process for a binding agreement that would jumpstart R&D for unmet medical needs. 

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches